Pancreatic Cancer Treatment Market to Surge to USD 10.2 Billion by 2034, Driven by Advancements in Immunotherapies and Early Diagnostics – Transparency Market Research
February 06, 2025 11:00 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research Inc. - , Feb. 06, 2025 (GLOBE NEWSWIRE) -- The Pancreatic Cancer Treatment Market is set for remarkable growth, projected to reach...
CytoMed Therapeutics announces Chairman’s Letter to the Company’s shareholders
February 06, 2025 07:20 ET
|
CYTOMED THERAPEUTICS LIMITED
SINGAPORE, Feb. 06, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or the “Company”) today released a letter to shareholders from the Chairman of the Company’s Board...
Medicenna Therapeutics to Participate in Two Healthcare Investor Conferences in February 2025
February 05, 2025 07:00 ET
|
Medicenna Therapeutics Corp.
TORONTO and HOUSTON, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused...
Non-Muscle Invasive Bladder Cancer Market Poised for $21.1 Bn Surge by 2034, Driven by Expanding Therapeutic Innovations | Transparency Market Research
January 31, 2025 09:45 ET
|
Transparency Market Research
Wilmington, Delaware, Transparency Market Research Inc. –, Jan. 31, 2025 (GLOBE NEWSWIRE) -- The global non-muscle invasive bladder cancer (NMIBC) market (非筋肉浸潤性膀胱癌市場), valued at US$ 2.6 billion in...
Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on February 5
January 29, 2025 08:00 ET
|
Calidi Biotherapeutics, Inc
SAN DIEGO, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor...
Cancer Immunotherapy Market, Valued at $125.68 Billion in 2025, Sees $194.64 Billion Opportunity by 2029 - Dominated by Amgen, AstraZeneca, Roche, Bayer, and Eli Lilly
January 28, 2025 11:29 ET
|
Research and Markets
Dublin, Jan. 28, 2025 (GLOBE NEWSWIRE) -- The "Cancer Immunotherapy Market Report 2025" has been added to ResearchAndMarkets.com's offering.This Cancer Immunotherapy market report covers market...
CD137 Antibodies Market Research 2024-2027: Increasing Investment in the Cancer Therapeutics Domain, Involvement of Prominent Companies Driving the CD137 Market
January 28, 2025 11:13 ET
|
Research and Markets
Dublin, Jan. 28, 2025 (GLOBE NEWSWIRE) -- The "CD137 Antibodies Clinical Trials & Market Opportunity Insight" report has been added to ResearchAndMarkets.com's offering. The market potential...
Calidi Biotherapeutics Announces Bolstered Cash Balance and Termination of its Standby Equity Purchase Agreement
January 28, 2025 08:00 ET
|
Calidi Biotherapeutics, Inc
SAN DIEGO, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor...
Greenwich LifeSciences Announces Activation of Flamingo-01 in Poland
January 27, 2025 06:00 ET
|
Greenwich LifeSciences, Inc.
STAFFORD, Texas, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial,...
Biosimilars Market Size is Projected to Reach USD 121.88 Billion by 2033, Growing at a CAGR of 15.56%: Straits Research
January 23, 2025 09:30 ET
|
Straits Research Private Limited - Garner Insights
New York, United States, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Biosimilars, also known as follow-on biologics, are made by a different business but look and work much like the original medicine....